SuperHealthy Rx advertises a bundle covering compounded medication, clinical review and shipping. The offer checked on October 5, 2026 lists semaglutide at $85 per month and tirzepatide at $135. Its seasonal sale wording makes current checkout confirmation especially important.
Identify the care pathway
The offer refers to the MD Integrations network and licensed US pharmacy partners. These are statements on the provider's page, not the result of an independent credential audit by our publication. Ask for the actual prescriber and dispensing pharmacy connected to your care.
Then ask how to reach them after the initial order. A service can provide helpful administrative support while still needing a separate route for medication instructions or symptoms. Save the clinical and pharmacy contacts rather than assuming every support channel has the same role.
Resolve the product question
The medicines described are compounded and are not FDA-approved. Discuss the reason for that preparation with the prescriber. Do not interpret marketing references to an ingredient's studies as proof that a particular compounded product has undergone FDA review.
When a pharmacy is identified, FDA's BeSafeRx resources can help locate the relevant licensing information. Keep the verification tied to the actual pharmacy, not just a generic claim that the service uses licensed partners.
Check the order settings
The offer describes optional automatic refills and no separate membership charge. Confirm what has been selected on your own order and when any further payment would occur. A refill preference is an administrative setting, not a treatment instruction.
SuperHealthy is promotional #2 here. We have not tested its fulfillment, clinician availability or handling of safety concerns. This profile identifies questions to resolve before relying on the service, rather than certifying it as safer than another option.
Sources and limits
Checked October 5, 2026. Federal sources provide general guidance; provider pages describe advertised terms. These sources do not assess an individual patient's situation.
- SuperHealthy Rx — current GLP-1 offerProvider offer
- FDA — concerns with unapproved GLP-1 drugsRegulator guidance
- FDA BeSafeRx — online pharmacy informationPharmacy verification and reporting resources